8 August 2018PatentsWeiwei Han

Questions of novelty in medical use patents

When a substance with a diagnostic or therapeutic effect per se has been available in the prior art, it will become more important to effectively protect the medical use of the substance, particularly in a jurisdiction (such as China) where diagnostic or therapeutic methods are not patent-eligible.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at

More on this story

11 March 2014   China’s patent office received 825,000 applications for invention patents last year, the agency has revealed.
7 April 2020   China has surpassed the US as the top source of international patent applications filed with the World Intellectual Property Organization for the first time in over 40 years, according to newly-released statistics from the UN body.